11beta-Prostaglandin E1,
24570-01-2,
UNII-U0DO49Q8Y4,
11-beta-PGE1,
11-beta-Prostaglandin E1,
U0DO49Q8Y4,
9-oxo-11S,15S-dihydroxy-13E-prostaenoic acid,
11-Epiprostaglandin E1,
11-epi-PGE1,
Alprostadil impurity E [EP],
AC1NR1IQ,
11.beta.-Prostaglandin E1,
GMVPRGQOIOIIMI-FZYGRIMQSA-N,
HMS3648B05,
ZINC5978194,
1144AH,
LMFA03010106,
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11beta,13E,15S)-,
7-((1R,2R,3S)-3-Hydroxy-2-((1E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid,
SR-01000946398,
J-015574,
SR-01000946398-1,
9-Oxo-11.beta.,15S-dihydroxyprost-13E-en-1-oic acid,
(13E,15S)-11beta,15-Dihydroxy-9-oxoprosta-13-ene-1-oic acid,
7-((1R,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid,
7-[(1R,2R,3S)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid,
alprostadil,
11BETA-PROSTAGLANDINE1,
FA(20:1(OH2,Ke,cyclo)),
C20H34O5,
CID5283098,